» Articles » PMID: 17928594

Hematopoietic-cell Transplantation at 50

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2007 Oct 12
PMID 17928594
Citations 157
Authors
Affiliations
Soon will be listed here.
Citing Articles

The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT.

Passweg J, Baldomero H, Atlija M, Kleovoulou I, Witaszek A, Alexander T Bone Marrow Transplant. 2025; .

PMID: 39939433 DOI: 10.1038/s41409-025-02524-2.


Dual-Double Stem Cell Ovarian Therapy: A Comprehensive Approach in Regenerative Medicine.

Ljubic A, Dinic M, Svraka D, Vujovic S Int J Mol Sci. 2025; 26(1.

PMID: 39795929 PMC: 11719681. DOI: 10.3390/ijms26010069.


Utilization of hematopoietic cell transplantation and cellular therapy technology in Europe and associated Countries. Using the 2022 activity survey data to correlate with economic and demographic factors. A report from the EBMT.

Passweg J, Baldomero H, Alexander T, Angelucci E, Averbuch D, Bazarbachi A Bone Marrow Transplant. 2024; 60(2):227-236.

PMID: 39578528 PMC: 11810786. DOI: 10.1038/s41409-024-02459-0.


Cardiovascular Disease After Hematopoietic Stem Cell Transplantation in Adults: State-of-the-Art Review.

Gent D, Saif M, Dobson R, Wright D JACC CardioOncol. 2024; 6(4):475-495.

PMID: 39239331 PMC: 11372032. DOI: 10.1016/j.jaccao.2024.06.004.


Recent advances in acute gastrointestinal graft versus host disease (aGvHD): aspects of steroid-resistant disease.

Kujawska J, Zeiser R, Gil L Ann Hematol. 2024; .

PMID: 39207560 DOI: 10.1007/s00277-024-05952-0.